Garner B - Search Results

1

Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration.

Glaros EN, Kim WS, Wu BJ, Suarna C, Quinn CM, Rye KA, Stocker R, Jessup W, Garner B. Glaros EN, et al. Among authors: garner b. Biochem Pharmacol. 2007 May 1;73(9):1340-6. doi: 10.1016/j.bcp.2006.12.023. Epub 2006 Dec 27. Biochem Pharmacol. 2007. PMID: 17239824

2

Analysis of apolipoprotein E nuclear localization using green fluorescent protein and biotinylation approaches.

Kim WS, Elliott DA, Kockx M, Kritharides L, Rye KA, Jans DA, Garner B. Kim WS, et al. Among authors: garner b. Biochem J. 2008 Feb 1;409(3):701-9. doi: 10.1042/BJ20071261. Biochem J. 2008. PMID: 17961126

3

Myriocin slows the progression of established atherosclerotic lesions in apolipoprotein E gene knockout mice.

Glaros EN, Kim WS, Quinn CM, Jessup W, Rye KA, Garner B. Glaros EN, et al. Among authors: garner b. J Lipid Res. 2008 Feb;49(2):324-31. doi: 10.1194/jlr.M700261-JLR200. Epub 2007 Oct 31. J Lipid Res. 2008. PMID: 17978313 Free article.

4

Reduction of plasma glycosphingolipid levels has no impact on atherosclerosis in apolipoprotein E-null mice.

Glaros EN, Kim WS, Rye KA, Shayman JA, Garner B. Glaros EN, et al. Among authors: garner b. J Lipid Res. 2008 Aug;49(8):1677-81. doi: 10.1194/jlr.E800005-JLR200. Epub 2008 May 8. J Lipid Res. 2008. PMID: 18467744 Free article.

5

Macrophage apolipoprotein-E knockdown modulates caspase-3 activation without altering sensitivity to apoptosis.

Elliott DA, Kim WS, Jans DA, Garner B. Elliott DA, et al. Among authors: garner b. Biochim Biophys Acta. 2008 Feb;1780(2):145-53. doi: 10.1016/j.bbagen.2007.10.021. Epub 2007 Nov 7. Biochim Biophys Acta. 2008. PMID: 18047842

6

Myriocin-mediated up-regulation of hepatocyte apoA-I synthesis is associated with ERK inhibition.

Glaros EN, Kim WS, Garner B. Glaros EN, et al. Among authors: garner b. Clin Sci (Lond). 2010 Mar 30;118(12):727-36. doi: 10.1042/CS20090452. Clin Sci (Lond). 2010. PMID: 20102334 Free PMC article.

7

Selective reduction of hydroperoxyeicosatetraenoic acids to their hydroxy derivatives by apolipoprotein D: implications for lipid antioxidant activity and Alzheimer's disease.

Bhatia S, Knoch B, Wong J, Kim WS, Else PL, Oakley AJ, Garner B. Bhatia S, et al. Among authors: garner b. Biochem J. 2012 Mar 15;442(3):713-21. doi: 10.1042/BJ20111166. Biochem J. 2012. PMID: 22150111

8

Induction of fibroblast apolipoprotein E expression during apoptosis, starvation-induced growth arrest and mitosis.

Quinn CM, Kågedal K, Terman A, Stroikin U, Brunk UT, Jessup W, Garner B. Quinn CM, et al. Among authors: garner b. Biochem J. 2004 Mar 15;378(Pt 3):753-61. doi: 10.1042/BJ20031352. Biochem J. 2004. PMID: 14656220 Free PMC article.

9

Glycosphingolipid accumulation inhibits cholesterol efflux via the ABCA1/apolipoprotein A-I pathway: 1-phenyl-2-decanoylamino-3-morpholino-1-propanol is a novel cholesterol efflux accelerator.

Glaros EN, Kim WS, Quinn CM, Wong J, Gelissen I, Jessup W, Garner B. Glaros EN, et al. Among authors: garner b. J Biol Chem. 2005 Jul 1;280(26):24515-23. doi: 10.1074/jbc.M413862200. Epub 2005 May 11. J Biol Chem. 2005. PMID: 15890646 Free article.

10

Fine tuning therapeutic targeting of the sphingolipid biosynthetic pathway to treat atherosclerosis.

Kim WS, Chalfant CE, Garner B. Kim WS, et al. Among authors: garner b. Curr Vasc Pharmacol. 2006 Apr;4(2):151-4. doi: 10.2174/157016106776359844. Curr Vasc Pharmacol. 2006. PMID: 16611156 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters